US FDA APPROVES USE OF FIRST AI DIAGNOSTIC DEVICE

摘要

A screening device that uses artificial intelligence (Al) to eliminate the need for a clinician to interpret results has been authorised for use for the first time in the United States. The US Food and Drug Administration has approved the marketing of a device that uses Al to determine whether a person with diabetes has more than mild diabetic retinopathy.